- Research article
- Open Access
- Open Peer Review
Tetramethylpyrazine attenuates spinal cord ischemic injury due to aortic cross-clamping in rabbits
© Chen et al; licensee BioMed Central Ltd. 2002
- Received: 8 December 2001
- Accepted: 17 April 2002
- Published: 17 April 2002
Lower limb paralysis occurs in 11% of patients after surgical procedure of thoracic or thoracoabdominal aneurysms and is an unpredictable and distressful complication. The aim of this study was to investigate the effects of tetramethylpyrazine (TMP), an intravenous drug made from traditional Chinese herbs, on the neurologic outcome and hisotpathology after transient spinal cord ischemia in rabbits.
Forty-five male New Zealand white rabbits were anesthetized with isoflurane and spinal cord ischemia was induced for 20 min by infrarenal aortic occlusion. Animals were randomly allocated to one of five groups (n = 8 each). Group C received no pharmacologic intervention. Group P received intravenous infusion of 30 mg·kg-1 TMP within 30 min before aortic occlusion. Group T1, Group T2 and Group T3 received intravenous infusion of 15, 30 and 60 mg·kg-1 TMP respectively within 30 min after reperfusion. In the sham group (n = 5), the animals underwent the same procedures as the control group except infrarental aortic unocclusion. Neurologic status was scored by using the Tarlov criteria (in which 4 is normal and 0 is paraplegia) at 4 h, 8 h, 12 h, 24 h, and 48 h after reperfusion. All animals were sacrificed at 48 h after reperfusion and the spinal cords (L5) were removed immediately for histopathologic study.
All animals in the control group became paraplegic. Neurologic status and histopathology (48 h) in the Groups P, T2 and T3 were significantly better than those in the control group (P < 0.05). There was a strong correlation between the final neurologic scores and the number of normal neurons in the anterior spinal cord (r = 0.776, P < 0.01).
Tetramethylpyrazine significantly reduces neurologic injury related to spinal cord ischemia and reperfusion after aortic occlusion within a certain range of dose.
- Spinal Cord
- Middle Cerebral Artery Occlusion
- Spinal Cord Ischemia
- Aortic Occlusion
- Lower Extremity Function
Spinal cord ischemic injury remains a devastating and unpredictable complication, which develops paralysis or paraplegia in proximately 11~40% of patients undergoing descending thoracic or thoracoabdominal aneurysm repair [1, 2]. Therefore, a great number of efforts have been focused on solving this problem, which include surgical techniques, pharmacologic intervention and mechanical methods, used such as hypothermia, cerebrospinal fluid drainage, and retrograde venous perfusion [3–6]. The cellular and molecular mechanisms of ischemic spinal cord injury are not fully understood. But multiple studies have suggested that calcium overload, free radical production, platelet aggregation, neutrophil accumulation and adhesion following ischemia may contribute to neuronal ischemic spinal cord injury [4, 8]. Pharmacologic studies have demonstrated tetramethylpyrazine (TMP), an intravenous drug made from traditional Chinese herbs, was able to inhibit release of intracellular calcium and to scavenge oxygen free radicals [9, 10]. The significant efficacy of TMP in cerebral ischemia and reperfusion injury was confirmed [11, 12]. However, no study has been designed to examine it's use in spinal cord ischemia. This study was designed to investigate the protective efficacy and the dose-response relationship of TMP against the neurologic and histophathologic outcomes of spinal cord ischemia and reperfusion injury relating to aortic occlusion in rabbits.
Forty-five male New Zealand White rabbits (provided by Experimental Animal Center of the Fourth Military Medical University), weighing 1.8 to 2.6 kg, were randomly assigned to one of six groups (n = 8 each). In the control group, the animals underwent infrarental aortic occlusion and intravenous infusion of 0.9% sodium chloride (volume was identical to those of TMP infusion). In protection group (Group P), the animals received 30 mg·kg-1 TMP within 30 min before aortic occlusion. In treatment groups T1, T2 and T3, the animals received 15,30 and 60 mg·kg-1 TMP respectively at the onset of reperfusion. In the sham group (n = 5), the animals underwent the same procedures as control group except infrarental aortic unocclusion. The TMP (Changzhou Pharmacological Co., China, NO: 990129), diluted in 10 ml of 0.9% sodium chloride, was intravenously infused at a rate of 20 ml·h-1 by using microinjector (3 M, Model 600, USA).
Spinal Cord Ischemia
The spinal cord ischemia was induced based on the method previously described by Wakamatsu et al . After an overnight fast with unrestricted access to water, the rabbits were induced in plastic box with 4% isoflurane in oxygen. Animals were allowed to breath spontaneously. Anesthesia was maintained by inhalation of 2%~3% isoflurane in oxygen administered by face mask at a flow rate of 4l·min-1. The left ear vein was cannulated with a 24-gauge catheter for the infusion of lactated Ringer's solution and TMP, the right ear artery was cannulated with a 24-gauge catheter for the measurement of proximal arterial blood pressure and for drawing blood samples. The distal arterial blood pressure was measured via a 24-gauge catheter inserted into the right femoral artery. With the rabbits in the prone position, the abdomen was opened through a vertical midline incision to expose the abdominal aorta. The aorta and its branches were meticulously dissected from caudal to the left renal artery. Heparin (150 U·kg-1) was given and intravenously a circumaortic occlusion device was placed across the aorta just distal to the left renal artery to occlude blood supply to the lumbar spinal cord. Spinal cord ischemia was induced by pulling the device. After a previously established ideal ischemic time of precisely 20 minutes, the device was removed, thus beginning reperfusion. After completion of surgery, the aorta was detected to be intact, and the abdominal wall was closed with 4-0 nylon suture in separate layers. The local infiltration around the wound with 0.25% bupivacaine hydrochloride was applied for postoperative analgesia. The animals were administered gentamicin (40,000 U) i.m., and allowed to recover with free access to food and water. During the procedure, lactated Ringer's solution was infused via ear vein. Proximal and distal arterial blood pressure and heart beat were continuously monitored (Spacelab, model 90206A, USA), body temperature was continuously monitored with a flexible probe (509 Monitor, USA) inserted 5 cm into the rectum and core temperature was maintained at 38~39°C by heating lamps. Arterial blood was sampled for determination of blood gases (AVL-2, Switzerland) and plasma glucose (One Touch II, USA) at 20 minutes before ischemia, 10 minutes after ischemia and 20 minutes after reperfusion respectively.
At 4 h, 8 h, 12 h, 24 h, and 48 h after perfusion, the motor function scores (MFS) were scaled in all rabbits by an observer unaware of the treatment group using the modified Tarlov criteria  as follows: 0: paraplegic with no lower extremity function;1: poor lower extremity function, weak antigravity movement only; 2: some lower extremity function with good antigravity strength but inability to draw legs under body; 3: ability to draw under body and hop, but not normally; 4: normal motor function.
After completion of the MFS at 48 h, the animals were re-anesthetized with 2% sodium pentobarbital, and transcardial perfusion and fixation were performed with 1000 mL of heparinized saline followed by 500 mL 10% phosphate-buffered formalin. The spinal cord was removed and refrigerated in 10% phosphate-buffered formalin for 48 h, then was embedded in paraffin. Coronal section of the spinal cord (L5 level) was cut at the thickness of 6 μm and stained with hematoxylin and eosin. Neuronal injury was evaluated at 200 × magnification by an observer unaware of the treatment group.
Values are expressed as mean ± SD. The physiologic variables were analyzed with repeated measures analysis of variance (ANOVA). The hindlimb motor function and the number of normal neurons in the anterior spinal cord were analyzed using a nonparametric method (Kruskal-Wallis test) followed by the Mann-Whitney U-test with Bonferroni correction. The correlation of hindlimb motor function scores and the number of normal neurons in the anterior spinal cord were analyzed using Spearman's rank correlation. A P value < 0.05 was considered statistically significant.
Physiologic and hemodynamic parameters
Physiologic variables are shown in Table 1 (see additional file 1) . Rectal temperature, heart rate, and mean arterial blood pressure were not affected by the slow infusion of TMP. There were no statistical differences in the physiologic parameters of the animals among the five groups. PaO2, PaCO2 and arterial oxygen saturation were within normal range in all animals.
Correlation between motor function scores and the numbers of normal neurons at anterior spinal cord
There was a strong correlation between the final neurologic outcome and the numbers of normal neurons in anterior spinal cord 48 h after reperfusion (r = 0.776, P < 0.01).
The present study demonstrated that TMP by intravenous administration before or after aortic occlusion significantly ameliorates transient spinal cord ischemia (20 min) produced by occlusion of the infrarenal aorta in rabbits. No obvious dose-response effect was observed within the dose range studied in the present study.
Partial to complete paralysis during the early postoperative period is an unfortunate and unpredictable consequence of operation on the descending thoracic or thoracoabdomina aorta or direct spinal cord surgery for tumors. Neurologic deficits may be noted during the immediate postoperative period or may be manifested many hours after operation, which severely affluences surgical outcome, and leads to massive psychological and financial burden. Multiple studies [3–6] have been done to examine the effects of various pharmacologic agents on spinal cord ischemia, but no clinically effective treatments have yet been developed. TMP, one of the alkaloids in ligusticum Wallichii Franch (L. Wallichill), an active ingredient in Chuanxiong, has been widely used, especially in the treatment of patients with cerebrovasular ischemic diseases in China and manifested its therapeutic actions in clinic [14, 15]. TMP has been demonstrated to provide significant protective properties against acute brain ischemic injury induced by ligation of bilateral common carotid arteries (2VO) in gerbils and cerebral infarction produced by middle cerebral artery occlusion (MCAO) in rats in experimental studies [11, 12], but limited data exist regarding the use of TMP in spinal cord injury. The rabbit model of spinal cord ischemia used in this study, which mimics aortic occlusion during operation on the thoracoabdominal aorta in clinic, is a reliable and reproducible model for producing neurologic deficit and testing drugs that might serve to protect the spinal cord from ischemic injury .
There was significant improvement in the neurologic outcomes of rabbits that received TMP comparing with the control group. Both protective group and treated group with the same dose of TMP had higher Tarlov scores than that in the control animals. Animals treated with TMP before aortic occlusion had 100% recovery at 48 h. These animals were able to stand without difficulty and hop normally. Except for one rabbit treated with TMP at the onset of reperfusion, other animals reached a median Tarlov score of 3 after 48 h with standing or hopping. In contrast, control animals showed paralysis of the hind limbs. It was confirmed in present study that the motor function scores at different time points and the number of normal neurons in the anterior spinal cord at 48 h in the two groups received treatment of TMP 30 and 60 mg·kg-1 after reperfusion were significantly better and greater respectively than those in the control group. Animals treated with 15 mg·kg-1 TMP did not show any neurologic and histopathologic improvements, indicating a enough dose of TMP is needed to have therapeutic effect on spinal cord ischemic injury. These results are not consistent with a recent study  examining the protective effects of TMP on cerebral infarction produced by middle cerebral artery occlusion (MCAO) in rats. Cen et al  demonstrated that TMP 10, 20, 40 mg·kg-1 given intravenously markedly improved the abnormal nervous symptoms in rats, significantly reduced the infarct volume at 24 h after MCAO, and presented a certain dose-response relation. This study showed that lower dosage of TMP produced inadequate protective effects against ischemic spinal cord injury. The differences may be result of different animal species and model.
Histologic examination confirmed the ability of TMP to limit neuronal degeneration and necrosis in the anterior horn motor neurons. Histologic examination of the spinal cords revealed either no evidence or very little evidence of injury in TMP-prevented rabbits, whereas spinal cords from control animals had evidence of extensive spinal cord injury with central gray matter necrosis, perikaryal swelling, vacuolization of anterior horn motor neurons, Nissl substance dissolution, and karyolysis. These morphologic changes developed after ischemia and caused the physiologic and clinic consequences observed after ischemic disturbance. The number of normal neurons at anterior spinal cord has direct relations with neurologic function, which was manifested by a strong correlation between the final neurologic outcomes and the number of normal neurons at anterior spinal cord.
The mechanism of motor neuronal cell death after spinal cord ischemia and reperfusion has been explored through molecular, cellular and genic aspects, but it has not been yet identified. Evidence is gathering that a various of factors induced over-accumulation of intracellular calcium triggers proteases, lipase, protein kinase C, nitric oxide synthase, endonucleases, altered gene transcription, and release of free radicals, eventually producing neuronal injury and death. The present study did not explore the protective mechanism of TMP on motor neurons after spinal cord ischemia. According to pharmacology of TMP and studies for effects of TMP on cerebral ischemic injury, antiplatelet activation and aggregation, dilating arterioles to improve microcirculation [17, 18], scavenging free radicals, increasing the activity of SOD and decreasing lipid peroxidation , inhibiting calcium overload , reducing the production of nitric oxide and dynorphin A1-13 in ischemic tissue [19, 20], decreasing the protein expression of c-fos and increasing the protein expression of bcl-2 and heat shock protein 70(HSP 70) [21, 22]may be mechanisms for protection of TMP against spinal cord ischemia /reperfusion injury. The injection of TMP is a pure extract from Chinese herbs, and has the properties of abundant resources, cheapness, wide range of dose in clinic and few side effects. Thus we anticipate that TMP might have important clinical application as a treatment in the prevention of spinal cord injury during thoracoabdominal aortic operations.
It can be concluded from these experiments that tetramethylpyrazine (TMP), an intravenous drug made from traditional Chinese herbs, significantly improves the neurologic injury secondary to spinal cord ischemia and reperfusion after aortic occlusion for 20 minutes in the rabbit.
This study was supported by a grant-in-aid for "tenth five-year plan" scientific research on medicine from PLA of China (NO. 01M118).
- Crawford ES, Crawfrod JL, Safi HJ, Coselli JS, Hess KR, Brooks B, Norton HJ, Glaeser DH: Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg. 1986, 3: 389-404. 10.1067/mva.1986.avs0030389.View ArticlePubMedGoogle Scholar
- Kouchoukos NL, Rokkas CK: Descending thoracic and thoracoabdominal aortic surgery for aneurysm or dissection: how to we minimize the risk of spinal core injury?. Semin Thorac Cardiovasc Surg. 1993, 5: 47-54.PubMedGoogle Scholar
- Lang-Lazdunski L, Heurteaux C, Vaillant N, Widmann C, Lazdunski M: Riluzle prevents ischemic spinal cord injury caused by aortic crossclamping. J Thorac Cardiovasc Surg. 1999, 117: 881-889.View ArticlePubMedGoogle Scholar
- Danielisova V, Chavko M: Comparative effects of the N-Methyl-D-aspartate antagonist MK-801 and the calcium channel blocker KB-2796 on neurologic and metabolic recovery after spinal cord ischemia. Exp Neurol. 1998, 149: 203-208. 10.1006/exnr.1997.6680.View ArticlePubMedGoogle Scholar
- Matsumoto M, Iida Y, Wakamastu H, Ohtake K, Nakakimura K, Xiong LZ, Sakabe T: The effects of NG-nitro-L-Arginine-Methyl ester on neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits. Anesth Analg. 1999, 89: 696-702.PubMedGoogle Scholar
- Wakamatsu H, Matsumoto M, Nakakimura K, Sakabe T: The effects of moderate hypothermia and intrathecal tetracaine on glutamate concentrations of intrathecal dialysate and neurologic and histopathologic outcome in transient spinal acrd ischemia in rabbits. Anesth Analg. 1999, 88: 56-62.PubMedGoogle Scholar
- Hall ED, Wolf DL: A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia. J Neurosurg. 1986, 64: 951-961.View ArticlePubMedGoogle Scholar
- Agee JM, Flanagn T, Blackbourne LH, et al: Reducing postischemic paraplegia using conjugated superoxide dismutase. Ann Thorac Surg. 1991, 51: 911-915.View ArticlePubMedGoogle Scholar
- Kwan CY, Daniel CE, Chen MC: Inhibition of vasoconstriction by tetramethylpyrazine :does it act by blocking the voltage-dependent Ca2+ channel?. J Cardiovasc Pharmacol. 1990, 15: 157-162.View ArticlePubMedGoogle Scholar
- Zhang ZH, Yu SZ, Wang ZT, Zhao BL, Hou JW, Yang FJ, Xin WJ: Scavenging effects of tetramethylpyrazine on active oxygen free radicals. Acta Pharmacol Sin. 1994, 5: 229-231.Google Scholar
- Xiao SH, Ge JW: Protection of tetramethylpyrazine on cerebral ischemia and reperfusion injury in rats. J Trad Chin Med. 1993, 18: 35-436.Google Scholar
- Cen DY, Chen ZW, Song BW, Wang Y, Fang M, Jiang Q, Ma CG: The protective effect of ligustrazine on cerebral infarction in rats. Chin Pharmacol Bul. 1999, 15: 464-466.Google Scholar
- Tarlov IM: Acute spinal cord compression paralysis. J Neurosurg. 1972, 36: 10-20.View ArticlePubMedGoogle Scholar
- Zhang JL, Shi ZX, Mao JS, Zhang TL, Huang L, Li HC, Shi YT, HY' Zhang, Zi BH: Clinical study of Naoxin Sutong in treating patients with acute cerebral infarction. Chin J Integ Trad & West Med. 1994, 14: 478-481.Google Scholar
- Men QN: Treatment of 38 cases of acute cerebral infarction with tetramethylpyrazine and Buyin Huanwu Tang. Integ Trad Chin & West Med Prac Cril Care Med. 1999, 6: 12-Google Scholar
- Moore WM, Hollier LH: The influence of severity of spinal cord ischemia in the etiology of delayed-onset of paraplegia. Ann Surg. 1991, 213: 427-431.View ArticlePubMedPubMed CentralGoogle Scholar
- Liu SY, Sylvester DM: Antiplatelet structure-activity relationship of tetramethylpyrazine. Life Sci. 1994, 55: 1317-1326. 10.1016/0024-3205(94)00764-0.View ArticlePubMedGoogle Scholar
- Liu SY, Sylvester DM: Antiplatelet activity of tetramethylpyrazine. Thromb Res. 1994, 75: 51-62.View ArticlePubMedGoogle Scholar
- Gan BX, Chen CF, Chen JW, Li XY, Wang Y: Effects of the therapy of Reinforcing Qi and activating circulation on acute cerebral ischemia and its mechanism. J Guangzhou Univ Trad Chin Med. 1999, 16: 41-44.Google Scholar
- Liu Z, Shi Y: Effects of ligusticum wallichii on the plasma and CSF levels of dynorphin A1-13 in rabbits under acute experimental cerebral ischemia. Chin J Integ Trad & West Med. 1990, 10: 160-161.Google Scholar
- Wang CX, Bao SY, Liu CF, Zhang ZL: Effects of nimodipine and ligustrazini on the protein expression of c-fos and bcl-2 after focal cerebral ischemia followed by reperfusion. Chin Crit Care Med. 1999, 11: 609-611.Google Scholar
- Li Y, Chen ZX, Xie A, Zhang SH, Gong WQ, Ciu ZX, Zang YM: Effect of tetramethylpyrazine on the HSP70 expression in rats with cerebral ischemic reperfusion injury. Chin J Intern Med. 1998, 37: 333-335.Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/2/1/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.